Long-term performance of laboratory developed LC-MS/MS tests and an FDA- approved immunoassay for the therapeutic drug monitoring of Everolimus

Bjoern Schniedewind

[O26-1-2] Long-term performance of laboratory developed LC-MS/MS tests and an FDA- approved immunoassay for the therapeutic drug monitoring of Everolimus

Bjoern Schniedewind¹, Uwe Christians², Eric J. Meyer³ (1.University of Colorado, 2.University of Colorado, 3.Pharmaceutical Corp.)

キーワード：everolimus, LC-MS/MS, Laboratory Developed Test, everolimus quantitative microsphere system assay, therapeutic drug monitoring

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

講演情報

[O26-1] O26-1: Immunosuppressive drugs: assey and genotyping

[O26-1-2] Long-term performance of laboratory developed LC-MS/MS tests and an FDA- approved immunoassay for the therapeutic drug monitoring of Everolimus

パスワード